0.00Open0.00Pre Close0 Volume0 Open Interest20.00Strike Price0.00Turnover185.06%IV-53.85%PremiumNov 15, 2024Expiry Date7.00Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9078Delta0.0445Gamma1.81Leverage Ratio-0.0317Theta-0.0035Rho-1.64Eff Leverage0.0034Vega
Elanco Animal Health Stock Discussion
3 mins ago
Elanco Receives FDA Approval for Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets), the Broadest(I) Canine Oral Parasiticide Protection in a Single Monthly Dose
No comment yet